Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Superparamagnetic Lipid-based Hybrid Nanosystems For Drug Delivery

E. Millart, S. Lesieur, V. Faivre
Published 2018 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Introduction: The development of multifunctional drug carriers provides many opportunities in the field of drug delivery. Among them, carriers loaded with both drug and superparamagnetic iron oxide nanoparticles would allow the combination of chemotherapy with the possibility of monitoring or controlling the distribution of the nanocarrier in the body, triggering drug release and/or applying a synergistic hyperthermia treatment. Areas covered: The present review covers biocompatible lipid-based nanotechnologies that have been employed to co-encapsulate drug and iron oxide. Depending on their physico-chemical properties, lipids are able to generate monophasic lipophilic nanodispersions or more complex structures containing both lipidic and aqueous domains. This review describes the rationale behind these nanoobjects and how they can be prepared. Expert opinion: This review focuses on the co-encapsulation aspects of these hybrid systems and discusses in particular the possible heterogeneities in drug-to-iron oxide ratio and the difficulties that could be encountered in the construction of these biocompatible multifunctional drug carriers.
This paper references
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1039/c7nr08488a
A scalable process to produce lipid-based compartmented Janus nanoparticles with pharmaceutically approved excipients.
Tri Truong-Cong (2018)
10.1016/J.JMMM.2005.02.077
Temperature change of various ferrite particles with alternating magnetic field for hyperthermic application
D. Kim (2005)
10.1016/J.JCIS.2007.01.081
Synthesis of bilayer oleic acid-coated Fe3O4 nanoparticles and their application in pH-responsive Pickering emulsions.
Q. Lan (2007)
10.1023/A:1011930127562
Long-Circulating Nanopartides Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate)
C. Passirani (2004)
10.1039/b906229g
On-chip manipulation of continuous picoliter-volume superparamagnetic droplets using a magnetic force.
K. Zhang (2009)
10.1016/J.JCONREL.2013.08.225
Magnetic field-responsive cubosomes containing magnetite and poly(N-isopropylacrylamide)
S. K. Hong (2013)
10.1021/LA061879K
Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
C. Zhang (2007)
Nanoscale. 2018;10:3654–3662
T Truong-Cong (2018)
10.1016/0304-8853(86)90731-6
Magnetic colloidal properties of ionic ferrofluids
J. Bacri (1986)
10.1109/TMAG.1981.1061188
Preparation of aqueous magnetic liquids in alkaline and acidic media
R. Massart (1981)
10.1016/j.msec.2014.07.055
Enhanced contrast efficiency in MRI by PEGylated magnetoliposomes loaded with PEGylated SPION: effect of SPION coating and micro-environment.
A. Carvalho (2014)
10.1016/j.ab.2013.12.001
Maximizing exosome colloidal stability following electroporation.
J. Hood (2014)
10.1002/wnan.36
Magnetic resonance relaxation properties of superparamagnetic particles.
Y. Gossuin (2009)
10.1016/j.biomaterials.2009.09.004
Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging.
P. Jarzyna (2009)
10.1016/j.colsurfb.2012.02.029
In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia.
Priyank Kulshrestha (2012)
10.1080/02652040500435444
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
10.1016/J.EJRAD.2005.11.040
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
A. Tanimoto (2006)
10.15171/bi.2016.23
Radiolabeled theranostics: magnetic and gold nanoparticles
S. Same (2016)
10.1006/JSSC.2001.9426
Influence of grain size, oxygen stoichiometry, and synthesis conditions on the γ-Fe2O3 vacancies ordering and lattice parameters
T. Belin (2002)
10.1016/J.JMMM.2010.12.019
Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: Preparation and characteristics
Xiaoying Ying (2011)
Through several papers, this group has built nanoemulsions with multiple functions as drug carriers, MRI and fluorescence imaging and targeting
10.1016/j.nano.2014.11.009
Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting.
A. Silva (2015)
10.1016/j.cis.2011.04.003
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)
10.1088/0957-4484/22/5/055102
Microwave assisted nanoparticle surface functionalization.
F. Benyettou (2011)
• An original way to control the drug release from cubosomes with a thermosensitive polymer in response to hyperthermia induced by SPION
RGD-Functionalized Superparamagnetic Nanoemulsions for Target-Specific Imaging of Tumor Angiogenesis
L. Deddens (2009)
10.1016/0730-725X(93)90241-5
Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI.
E. Canet (1993)
10.3390/ijms140815910
Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
R. Thomas (2013)
10.1016/j.jcis.2014.11.056
Magnetocubosomes for the delivery and controlled release of therapeutics.
C. Montis (2015)
10.1002/adbi.201700044
Extracellular Vesicle Production Loaded with Nanoparticles and Drugs in a Trade‐off between Loading, Yield and Purity: Towards a Personalized Drug Delivery System
Max Piffoux (2017)
10.1016/S0168-3659(96)01606-9
Release of 5-fluorouracil from thermosensitive magnetoliposomes induced by an electromagnetic field
E. Viroonchatapan (1997)
10.1088/0957-4484/27/8/085105
Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy.
R. V. Ferreira (2016)
10.1007/s10549-008-9948-x
Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes
T. Kikumori (2008)
10.1166/JNN.2008.15348
Superparamagnetism and other magnetic features in granular materials: a review on ideal and real systems.
M. Knobel (2008)
10.1016/j.ejpb.2013.01.028
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer.
B. Clares (2013)
10.1021/acs.bioconjchem.5b00590
Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis.
Khalid Oumzil (2016)
10.1039/C5RA18810E
Ferucarbotran, a carboxydextran-coated superparamagnetic iron oxide nanoparticle, induces endosomal recycling, contributing to cellular and exosomal EGFR overexpression for cancer therapy
Tsai-Hua Chung (2015)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after EXPERT OPINION ON DRUG DELIVERY 539 intravenous and intraduodenal administration
K Manjunath (2005)
10.1016/j.jphotobiol.2012.05.009
In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma.
G. C. Bolfarini (2012)
10.1515/ntrev-2014-0034
Colloidal magnetic nanocrystal clusters: variable length-scale interaction mechanisms, synergetic functionalities and technological advantages
A. Kostopoulou (2015)
10.1016/J.APSUSC.2006.05.023
Oleic acid coating on the monodisperse magnetite nanoparticles
L. Zhang (2006)
Renal Clearance of Nanoparticles
H. Choi (2009)
10.1021/ar2000277
Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Forrest M Kievit (2011)
Preparation and characterization of magnetic solid lipid nanoparticles loaded with ibuprofen
Xiujuan Pang (2009)
10.1002/ADFM.201402289
Superparamagnetic Liposomes for MRI Monitoring and External Magnetic Field-Induced Selective Targeting of Malignant Brain Tumors
H. Marie (2015)
10.1016/J.IJPHARM.2006.10.006
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
H. Ma (2007)
10.1007/s13402-012-0104-6
Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion
Iara F. Kretzer (2012)
10.1021/nn901824n
Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy.
S. Sharma (2010)
10.1016/J.JMMM.2010.08.008
Surface functionalization of chitosan-coated magnetic nanoparticles for covalent immobilization of yeast alcohol dehydrogenase from Saccharomyces cerevisiae
Guiyin Li (2010)
10.1039/c4nr04257c
Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
Bin Du (2015)
10.1039/c5sm02958a
Nanoemulsions: formation, properties and applications.
A. Gupta (2016)
Silica- and alkoxysilanecoated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging
C Zhang (2007)
Ferumoxtran-10 Advanced Magnetics.
W. Leenders (2003)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1016/J.EJPS.2005.08.001
Studies on the formation of O/W nano-emulsions, by low-energy emulsification methods, suitable for pharmaceutical applications.
Núria Sadurní (2005)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/j.jconrel.2017.03.008
Nanoemulsion: Concepts, development and applications in drug delivery
Yuvraj Singh (2017)
10.1515/ejnm-2014-0042
Magnetoliposomes: opportunities and challenges
C. A. Monnier (2014)
10.1021/cr300089t
Janus particles: synthesis, self-assembly, physical properties, and applications.
Andreas Walther (2013)
10.1039/c4cs00345d
Recent advances in magnetic nanoparticle-based multi-modal imaging.
Tae-Hyun Shin (2015)
10.1016/j.apsb.2016.02.001
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha (2016)
Neovasculature induced by vascular endothelial growth factor is fenestrated.
W. Roberts (1997)
Nanostructured materials for biomedical applications. Kerala: Transworld research network
M C Tan (2009)
10.1002/adhm.201500235
Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.
A. Grillone (2015)
10.1021/nl2001499
Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes.
E. Amstad (2011)
10.1016/S1040-8428(01)00179-2
The cellular and molecular basis of hyperthermia.
B. Hildebrandt (2002)
10.1007/s11095-014-1476-2
Preparation and Characterization of Cisplatin Magnetic Solid Lipid Nanoparticles (MSLNs): Effects of Loading Procedures of Fe3O4 Nanoparticles
S. Zhao (2014)
10.1007/s10856-009-3881-3
Synthesis of PVP-coated ultra-small Fe3O4 nanoparticles as a MRI contrast agent
Y. Zhang (2010)
10.1002/mrm.25376
Magnetic resonance imaging of melanoma exosomes in lymph nodes
L. Hu (2015)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1039/C2RA20135F
Cubic mesophase nanoparticles doped with superparamagnetic iron oxide nanoparticles: a new class of MRI contrast agent
D. Acharya (2012)
10.1016/J.COLSURFA.2009.01.024
Absorption of 10-hydroxycamptothecin into the coat of magnetoliposomes
M. Hodenius (2009)
10.1021/LA00038A065
The cubic phase region in the system didodecyldimethylammonium bromide-water-styrene
P. Stroem (1992)
10.1021/nn100274v
Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating.
Yanjing Chen (2010)
• Deep and well-conducted studies on the interactions between hydrophylic or hydrophobic SPION and cubic phases
10.1039/C1JM00060H
Magnetoliposome for alendronate delivery
F. Benyettou (2011)
10.1021/ol900949y
Water-soluble rhamnose-coated Fe3O4 nanoparticles.
Lenaic Lartigue (2009)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1364/BOE.3.002500
Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics
Rudolf Alwi (2012)
10.1038/SJ.JID.5701114
Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells.
Y. Shellman (2008)
10.1007/BF02524598
Ferrimagnetic fluids and ferro- and ferrimagnetic suspensions for the RF-induction hyperthermia of tumors
N. A. Brusentsov (2006)
10.2217/nnm-2016-0267
Combining nanoscale magnetic nimodipine liposomes with magnetic resonance image for Parkinson's disease targeting therapy.
Bingshuo Ji (2017)
10.1021/nn406349z
Insertion of nanoparticle clusters into vesicle bilayers.
C. Bonnaud (2014)
10.1002/wnan.122
Magnetoliposomes as magnetic resonance imaging contrast agents.
S. Soenen (2011)
10.1002/ijc.24864
Feasibility of chemohyperthermia with docetaxel‐embedded magnetoliposomes as minimally invasive local treatment for cancer
M. Yoshida (2010)
10.2217/nnm.11.14
Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
H. Fattahi (2011)
10.3390/molecules200611103
Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics
J. Albuquerque (2015)
10.1016/J.JMMM.2005.02.028
The heating effect of magnetic fluids in an alternating magnetic field
Xuman Wang (2005)
10.1517/17425247.2014.924501
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
10.1148/RADIOL.2283020872
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
Y. Anzai (2003)
10.1016/j.jconrel.2013.10.027
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity.
Y. Song (2014)
10.3109/9781420017267
Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs
D. Hauss (2007)
10.1002/JPS.2600640910
Apparent absorption kinetics of micronized griseofulvin after its oral administration on single- and multiple-dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension.
T. R. Bates (1975)
10.1002/ADFM.201001450
Anti‐Estrogen‐Loaded Superparamagnetic Liposomes for Intracellular Magnetic Targeting and Treatment of Breast Cancer Tumors
V. Plassat (2011)
10.1016/0169-409X(95)00043-7
Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents
S. Moghimi (1995)
10.1097/01.rli.0000184756.66360.d3
Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths
M. Rohrer (2005)
10.1016/j.colsurfb.2014.01.022
Low-dose chemotherapy of hepatocellular carcinoma through triggered-release from bilayer-decorated magnetoliposomes.
Yanjing Chen (2014)
10.18632/oncotarget.9671
Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application
H. Ye (2016)
10.1007/BF00256482
Magnetoliposomes. Formation and structural characterization.
M. de Cuyper (1988)
10.1097/01.rli.0000197669.80475.dd
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
P. Bourrinet (2006)
10.5772/15371
Equilibrium Properties of the Cellular Automata Models for Traffic Flow in a Single Lane
A. Salcido (2011)
10.1016/j.ejpb.2009.12.008
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
C. Chen (2010)
10.1155/2008/529890
Nanostructured materials for biomedical applications
D. Shi (2008)
10.1186/1477-044X-2-3
Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma
Fumiko Matsuoka (2004)
• A thorough in vitro work on microvesicles
10.1021/nn103336a
Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.
A. Gianella (2011)
10.1039/C2JM34327D
Carboxyl–polyethylene glycol–phosphoric acid: a ligand for highly stabilized iron oxide nanoparticles
Chichong Lu (2012)
10.1021/nn201348s
Water-soluble superparamagnetic magnetite nanoparticles with biocompatible coating for enhanced magnetic resonance imaging.
Lisong Xiao (2011)
10.1016/S1359-0294(00)00020-0
Surfactant self-assembly objects as novel drug delivery vehicles
C. Drummond (1999)
Interesting investigation and discussion on the incorporation of SPION into phospholipid bilayers
Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers
10.1111/j.1440-1746.2011.06972.x
Tumor local chemohyperthermia using docetaxel‐embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia
M. Yoshida (2012)
10.1248/BPB.30.350
Cubosomes: an overview.
Gopal Garg (2007)
10.1002/ADMA.200602326
A High‐Performance Magnetic Resonance Imaging T2 Contrast Agent
J. Qin (2007)
10.1016/S1773-2247(13)50004-9
Magnetic-fluid-loaded liposomes for MR imaging and therapy of cancer
H. Marie (2013)
10.1016/J.COCHE.2013.12.007
Towards designer nanoemulsions for precision delivery of therapeutics
F. Sainsbury (2014)
10.1021/cr300068p
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
10.1007/s10544-008-9192-5
Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery
Ming-Huang Hsu (2008)
10.1021/JP075235C
Structure and Properties of Iron Oxide Nanoparticles Encapsulated by Phospholipids with Poly(ethylene glycol) Tails
E. Shtykova (2007)
10.1021/JA071422C
Toward the syntheses of universal ligands for metal oxide surfaces: controlling surface functionality through click chemistry.
M. White (2006)
10.1021/nn506949t
Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes.
R. Di Corato (2015)
10.1016/j.addr.2012.07.002
Exosomes are endogenous nanoparticles that can deliver biological information between cells.
D. Sun (2013)
10.2147/IJN.S89679
Effect of superparamagnetic iron oxide nanoparticles on fluidity and phase transition of phosphatidylcholine liposomal membranes
P. B. Santhosh (2015)
Cytotoxicity of magnetiteloaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
RH Müller (1996)
Enhancing the bioavailability of poorly water soluble drugs
D J Hauss (2007)
10.1021/mp800240j
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta (2009)
10.1016/J.IJPHARM.2007.05.018
Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution.
V. Plassat (2007)
10.1016/J.EJPB.2007.07.006
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
R. Mueller (2008)
10.1016/j.jcis.2011.11.014
Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion.
Y. Chuan (2012)
10.1021/LA991366W
Aqueous-Phase Behavior and Cubic Phase-Containing Emulsions in the C12E2−Water System
M. Lynch (2000)
10.1016/J.JCONREL.2005.06.006
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
K. Manjunath (2005)
10.1021/acsami.6b12889
Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release.
Monika Szlęzak (2017)
10.3109/9781420017267
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs
J. Dressman (2007)
10.1021/JA0516460
Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.
Marie-Sophie Martina (2005)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.3109/10611869808997890
Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.
B. Bonnemain (1998)
Solid lipid nanoparticles: a potential multifunctional approach towards rheumatoid arthritis
J Albuquerque (2015)
10.1593/NEO.07940
Utility of a new bolus-injectable nanoparticle for clinical cancer staging.
M. Harisinghani (2007)
10.1021/JP0556310
Magnetic iron oxide nanoparticles for biorecognition: evaluation of surface coverage and activity.
Isaac Koh (2006)
10.3109/08982100903443065
Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability
J. Varshosaz (2010)
Development of Cuboidal Nanomedicine by Nanotechnology
B. Nanjwade (2014)
10.1002/EJOC.201402701
A Strategy for Multivalent Presentation of Carba Analogues from N. meningitidis A Capsular Polysaccharide
Daniela Ramella (2014)
10.1021/jp803016n
Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
M. Mahmoudi (2008)
10.1016/j.msec.2016.09.052
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Yinping Huang (2017)
10.1016/J.JIEC.2012.05.016
Preparation of iron oxide nanoparticles within monoolein cubic phase
S. K. Hong (2012)
10.1016/0730-725X(93)90470-X
Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
C. Chambon (1993)
10.1021/acsnano.5b06939
Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
Hongzhao Qi (2016)
10.1007/s11051-012-1100-5
Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications
M. Bloemen (2012)
10.3109/03639045.2010.497151
The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process
R. Yang (2011)
10.1016/j.nano.2011.02.007
Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake.
G. Bothun (2011)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)
10.1517/17425247.2014.915806
Janus nanoparticles: materials, preparation and recent advances in drug delivery
L. Tran (2014)
10.1557/PROC-676-Y7.8
Magnetic behavior of coated superparamagnetic iron oxide nanoparticles in ferrofluids
W. Voit (2001)
10.1007/S10856-007-3130-6
Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy
Sheng Liang (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar